CVS Health Corp (CVS) : Hartford Financial Management reduced its stake in CVS Health Corp by 0.08% during the most recent quarter end. The investment management company now holds a total of 60,253 shares of CVS Health Corp which is valued at $5,849,964 after selling 46 shares in CVS Health Corp , the firm said in a disclosure report filed with the SEC on Jul 14, 2016.CVS Health Corp makes up approximately 3.41% of Hartford Financial Management’s portfolio.
Other Hedge Funds, Including , Private Bank Trust Co reduced its stake in CVS by selling 930 shares or 9.72% in the most recent quarter. The Hedge Fund company now holds 8,637 shares of CVS which is valued at $836,666. CVS Health Corp makes up approx 0.13% of Private Bank Trust Co’s portfolio. Cutler Group Lp added CVS to its portfolio by purchasing 740 company shares during the most recent quarter which is valued at $72,246.Capital Insight Partners boosted its stake in CVS in the latest quarter, The investment management firm added 8,647 additional shares and now holds a total of 31,698 shares of CVS Health Corp which is valued at $3,066,465. CVS Health Corp makes up approx 2.89% of Capital Insight Partners’s portfolio.Daiwa Sb Investments Ltd. reduced its stake in CVS by selling 3,570 shares or 26.7% in the most recent quarter. The Hedge Fund company now holds 9,800 shares of CVS which is valued at $948,052. CVS Health Corp makes up approx 0.27% of Daiwa Sb Investments Ltd.’s portfolio.West Oak Capital boosted its stake in CVS in the latest quarter, The investment management firm added 550 additional shares and now holds a total of 20,395 shares of CVS Health Corp which is valued at $1,973,012. CVS Health Corp makes up approx 1.41% of West Oak Capital’s portfolio.
CVS Health Corp closed down -0.22 points or -0.23% at $96.87 with 35,71,222 shares getting traded on Monday. Post opening the session at $97.44, the shares hit an intraday low of $96.7637 and an intraday high of $97.69 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, CVS Health Corp reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on May 3, 2016. Analyst had a consensus of $1.16. The company had revenue of $43215.00 million for the quarter, compared to analysts expectations of $43000.77 million. The company’s revenue was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.
Many Wall Street Analysts have commented on CVS Health Corp. Shares were Reiterated by Mizuho on Jun 23, 2016 to “Buy” and Lowered the Price Target to $ 108 from a previous price target of $117 .Shares were Reiterated by Deutsche Bank on Jun 22, 2016 to “Hold” and Lowered the Price Target to $ 99 from a previous price target of $105 .CVS Health Corp was Downgraded by Morgan Stanley to ” Equal-Weight” on Jun 20, 2016.
CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.